Document is current
Any future updates will be listed below
-
Authors
Feinstein, James A. https://orcid.org/0000-0003-3074-8805
Bruckner, Anna L. https://orcid.org/0000-0002-2035-4127
Chastek, Benjamin
Anderson, Amy
Roman, Juan https://orcid.org/0000-0002-2807-3792
-
Funding
Funding for this research was provided by:
Krystal Bio
- License Information
-
More Information
Article History
Received: 9 May 2022
Accepted: 4 September 2022
First Online: 29 September 2022
Declarations
:
: WCG IRB (Puyallup, WA, USA) served as the IRB. IRB approval was obtained to review the deidentified physician notes. Patient privacy was preserved, and strict compliance with relevant Health Insurance Portability and Accountability Act data handling rules was observed throughout.
: Not applicable.
: AA is an employee of Optum. ALB reports grants from Amicus/Scioderm, Amryt Pharma, Castle Creek/Fibrocell, Phoenix Tissue Repair, and Phoenics. BC is an employee of Optum. JAF is Chair of the State of Colorado Medicaid Pharmacy and Therapeutics Committee. JR was an employee of Krystal Biotech when this study was conducted.
